Year |
Citation |
Score |
2022 |
Williams GP, Schonhoff AM, Sette A, Lindestam Arlehamn CS. Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease. Journal of Parkinson's Disease. PMID 35754290 DOI: 10.3233/JPD-223241 |
0.749 |
|
2022 |
Bostick JW, Schonhoff AM, Mazmanian SK. Gut microbiome-mediated regulation of neuroinflammation. Current Opinion in Immunology. 76: 102177. PMID 35462279 DOI: 10.1016/j.coi.2022.102177 |
0.306 |
|
2021 |
Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson disease. Brain : a Journal of Neurology. PMID 33704423 DOI: 10.1093/brain/awab103 |
0.741 |
|
2020 |
Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson's disease. Progress in Brain Research. 252: 169-216. PMID 32247364 DOI: 10.1016/bs.pbr.2019.10.006 |
0.743 |
|
2020 |
Williams GP, Marmion DJ, Schonhoff AM, Jurkuvenaite A, Won WJ, Standaert DG, Kordower JH, Harms AS. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathologica. PMID 31993745 DOI: 10.1007/S00401-020-02126-W |
0.722 |
|
2018 |
Schonhoff AM, Harms AS. Glial GLP1R: A novel neuroprotector? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30427545 DOI: 10.1002/mds.27547 |
0.533 |
|
2018 |
Williams GP, Schonhoff AM, Jurkuvenaite A, Thome AD, Standaert DG, Harms AS. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Journal of Neuroinflammation. 15: 244. PMID 30165873 DOI: 10.1186/S12974-018-1286-2 |
0.698 |
|
2017 |
Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Experimental Neurology. PMID 29155051 DOI: 10.1016/j.expneurol.2017.11.010 |
0.698 |
|
Show low-probability matches. |